Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

NCT00039130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: ifosfamide
DRUG: leucovorin calcium
DRUG: methotrexate
DRUG: prednisone
DRUG: vincristine sulfate
DRUG: Allopurinol

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]